CBX3 and neoplasm: In addition, since CBX3 has been linked to epigenetic changes such as H3K9me3, which plays a role in regulating the response to DNA damage, we speculate that it could potentially contribute to the resistance of tumor-initiating cells in NSCLC to antineoplastic drugs.